GlassScriptPhysician profile
Mehdi Razavi
NPI 1598867749
$358,111.66
in general payments reported to CMS, 2019-2025
35 companies · $8,470 in 2025
The $8,470 reported for 2025 was more than what 77% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30K · 2020: $29K · 2021: $157K · 2022: $37K · 2023: $57K · 2024: $40K · 2025: $8,470.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $75K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Food and Beverage: $8,104 · Education: $2,500 · Travel and Lodging: $1,777.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $74,700.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,250.00 |
| Food and Beverage | $8,104.12 |
| Education | $2,500.00 |
| Travel and Lodging | $1,776.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Irhythm Technologies, INC. | $202,117.27 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Saranas, INC. | $112,518.64 | 2021-2023 | |
| Boston Scientific Corporation | $20,611.20 | 2019-2025 | Versacross Access Solution, Rhythmia Mapping System, Watchman Access System |
| Abbott Laboratories | $7,780.33 | 2019-2025 | Aveir, Merlin@Home, Gallant |
| Biosense Webster, INC. | $6,397.34 | 2019-2025 | Carto 3, Visitag Surpoint External Processing Unit, Octaray Mapping Catheter |
| Lightforce Orthodontics, INC. | $2,701.63 | 2024 | |
| Medical Device Business Services, INC. | $2,700.00 | 2023 | Carto 3 |
| Impulse Dynamics (USA) INC. | $823.46 | 2022-2025 | Optimizer, Optimizer |
| Medtronic, INC. | $733.92 | 2021-2025 | Micra, Na, Corevalve Evolut R |
| Pfizer INC. | $216.57 | 2020-2024 | |
| Abiomed | $187.65 | 2019-2025 | |
| Medtronic Vascular, INC. | $182.35 | 2019 | |
| Cardiva Medical, INC. | $144.58 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Biotronik INC. | $118.01 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $110.69 | 2021-2022 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $97.62 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $84.11 | 2022-2025 | Camzyos, Eliquis |
| Elutia, INC. | $81.47 | 2019-2021 | |
| Novo Nordisk INC | $65.77 | 2024-2025 | |
| Baxter Healthcare | $64.41 | 2025 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Sanofi-Aventis U.S. LLC | $51.64 | 2022-2023 | |
| Evoke Pharma, INC. | $35.06 | 2020-2021 | |
| Kiniksa Pharmaceuticals International, Plc | $32.56 | 2024 | Arcalyst |
| Bardy Diagnostics, INC. | $30.00 | 2019 | |
| Itamar Medical INC | $29.38 | 2022 | |
| Esperion Therapeutics, INC. | $23.76 | 2025 | Nexletol |
| Kestra Medical Technology Services, INC. | $22.99 | 2025 | Assure Wcd |
| Astellas Pharma US INC | $21.13 | 2019 | |
| Bard Access Systems, INC. | $20.63 | 2022 | |
| Circa Scientific, INC. | $20.34 | 2025 | |
| Cvrx, INC. | $19.27 | 2022 | |
| Kiniksa Pharmaceuticals, LTD. | $18.68 | 2023 | Arcalyst |
| Haemonetics Corporation | $17.15 | 2024 | Ensoetm |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.89 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $15.16 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehdi Razavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.